Abstract
Objective
To describe etiology, clinical profile, treatment and outcome of children with pulmonary hemorrhage.
Methods
A chart review of children with pulmonary hemorrhage attending Pediatric Pulmonology services of a tertiary care hospital in North-India was done.
Results
Data of 44 children (mean age 59.2 ± 32.1 mo; 28 boys) were included for the study. Possible idiopathic pulmonary hemosiderosis 16 (36.4%), post infectious complications 11 (25%), immune mediated disorders 8 (18.2%), cardiac and vascular disorders 7 (15.9%), and airway pathologies 2 (4.5%) were the etiologies of pulmonary hemorrhage. Treatment options like medications, bronchial artery embolization and surgical resections were offered according to the etiology. Children with idiopathic pulmonary hemosiderosis and those with immune mediated diseases were treated with systemic steroids and steroid sparing agents; the latter group took longer time to respond and had more relapses.
Conclusions
Identification of main etiological categories of pulmonary hemorrhage in children could be useful to plan investigations and management of wide range of causes in more practical way.
Similar content being viewed by others
References
Lazor R. Alveolar haemorrhage syndromes. Eur Respir Mon. 2011;54:15–31.
Parris D, van Niekerk A, Jeevarathnum AC, Green RJ. An approach to pulmonary haemorrhage in children. S Afr Respir J. 2017;23:63–70.
Susarla SC, Fan LL. Diffuse alveolar hemorrhage syndromes in children. Curr Opin Pediatr. 2007;19:314–20.
Krause ML, Cartin-Ceba R, Specks U, Peikert T. Update on diffuse alveolar hemorrhage and pulmonary vasculitis. Immunol Allergy Clin N Am. 2012;32:587–600.
de Prost N, Parrot A, Cuquemelle E, et al. Diffuse alveolar hemorrhage in immunocompetent patients: etiologies and prognosis revisited. Respir Med. 2012;106:1021–32.
Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest. 2010;137:1164–71.
Kabra SK, Bhargava S, Lodha R, Satyavani A, Walia M. Idiopathic pulmonary hemosiderosis: clinical profile and follow up of 26 children. Indian Pediatr. 2007;44:333–8.
Taytard J, Nathan N, de Blic J, et al; French RespiRare® group. New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare® cohort. Orphanet J Rare Dis. 2013;8:161.
Zhang X, Wang L, Lu A, Zhang M. Clinical study of 28 cases of paediatric idiopathic pulmonary haemosiderosis. J Trop Pediatr. 2010;56:386–90.
Quadrelli S, Dubinsky D, Solis M, et al. Immune diffuse alveolar hemorrhage: clinical presentation and outcome. Respir Med. 2017;129:59–62.
Castellazzi L, Patria MF, Frati G, Esposito AA, Esposito S. Idiopathic pulmonary haemosiderosis in paediatric patients: how to make an early diagnosis. Ital J Pediatr. 2016;42:86.
Singh D, Bhalla AS, Veedu PT, Arora A. Imaging evaluation of hemoptysis in children. Ital J Pediatr. 2013;2:54–64.
Chin CIC, Kohn SL, Keens TG, Margetis MF, Kato RM. A physician survey reveals differences in management of idiopathic pulmonary hemosiderosis. Orphanet J Rare Dis. 2015;10:98.
Sethi GR, Singhal KK, Puri AS, Mantan M. Benefit of gluten-free diet in idiopathic pulmonary hemosiderosis in association with celiac disease. Pediatr Pulmonol. 2011;46:302–5.
Author information
Authors and Affiliations
Contributions
CDS: Data collection, interpretation and manuscript writing; AM, KRJ, RL and SKK: Data interpretation and critically evaluated the manuscript; SKK: Conceptualized the study and will act as the guarantor for the paper. All authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
None.
Rights and permissions
About this article
Cite this article
de Silva, C., Mukherjee, A., Jat, K.R. et al. Pulmonary Hemorrhage in Children: Etiology, Clinical Profile and Outcome. Indian J Pediatr 86, 7–11 (2019). https://doi.org/10.1007/s12098-018-2725-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-018-2725-x